Driving the Advancement
of Cutting-edge Science & Technology
of Cutting-edge Science & Technology

Improving next generation medicines
In addition, we are expanding the utility of our adjuvant technology by creating additional potential Matrix-based adjuvants including:
Expanding our efforts in infectious disease and beyond with differentiated programs in areas of unmet need.

We leverage a discovery model that is driven by artificial intelligence (AI) and machine learning. This approach enables us to leverage our deep in-house expertise coupled with extensive published scientific literature and modern computational techniques to optimize our product candidates’ efficacy, safety and tolerability.

Publications
Novavax has been at the forefront of R&D for decades and has contributed a wealth of information to the body of scientific knowledge. Learn more about our science and technology in our publications.